The pharmaceutical sector is seeing a important shift in diabetes care with the arrival of GLP-1 skin applications. These innovative methods offer a potentially simple alternative to subcutaneous injections for individuals managing type 2 diabetes. By bypassing the need for frequent needles, GLP-